BDNF and Alzheimer disease: These findings demonstrate that Qu can dose-dependently reverse the adverse effects of AlCl3, with BDNF levels in the AD + Qu25 and AD + Qu50 groups differing from the healthy control group by 32.07% and 7.89%, respectively.